Skip to content
WorldBrand.AI

Stelara

Product brand

UnclaimedRequest correction

STELARA® (ustekinumab) is a treatment option for psoriatic arthritis, plaque psoriasis, Crohn’s disease, and ulcerative colitis.

Last updated September 11, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

STELARA® (ustekinumab) is presented on its official site as a treatment option for adults with moderately to severely active Crohn’s disease, adults with moderately to severely active ulcerative colitis, and adults and children 6 years and older with moderate to severe plaque psoriasis or active psoriatic arthritis.

Sources2 sources

  1. 1Crohn’s Disease, Ulcerative Colitis, PsO & PsA Treatment | STELARA® (ustekinumab)stelarainfo.com
  2. 2Stelarawikidata.org

Cite this profile: Cite the canonical profile. /brand-wiki/stelara · Editorial policy · How profiles are compiled